Atlas Trials

A Combination of AKR1B10 and CA19-9 Improves the Diagnosis of PDAC

Clinical trial NCT04726956 · COMPLETED

Trial details

NCT number
NCT04726956
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
COMPLETED
Study type
OBSERVATIONAL
Pancreatic Ductal Adenocarcinoma
Start date
2021-02-01
Primary completion
2021-12-31
Enrollment
258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.